Tag: Nilesh Gupta
GENERAL Lupin Banks On Biosimilars, Specialty Medicines To Power Next Expansion

Lupin Ltd is stepping up its focus on biosimilars, specialty medicines, complex generics and artificial intelligence (AI) as it builds the next phase of its growth strategy, according to Chief Executive Officer Vinita Gupta and Managing Director Nilesh Gupta in a joint message to shareholders in the company’s Annual Report 2026. The leadership said years […]

CW Bureau · Jul 14, 2026
GENERAL Lupin Gets Clean Inspection Report From US FDA For Ankleshwar Plant

Pharma major Lupin has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Ankleshwar manufacturing facility in Gujarat following the closure of a product-specific pre-approval inspection conducted between March 2 and March 7, 2026. The receipt of the EIR marks the successful […]

CW Bureau · May 28, 2026